Medico Intercontinental Ltd — Others, 07-04-2025: Outcome of Board meeting

Intercontinental Ltd. has announced a board meeting to approve an investment of approximately ¥5.93 crores in Calborn Lifescience Private Limited. The investment will occur upfront or in tranches, with Calborn agreeing to allot shares at ₹30 per share, incorporating a premium. This move aims to acquire a 51% stake, making Calborn a subsidiary of Intercontinental. The investment reflects the company’s strategic interest in the pharmaceutical sector, which aligns with its objectives. This announcement may foster a positive outlook among investors, potentially enhancing Intercontinental’s position in a growing industry segment.